Caprico Biotechnologies, Inc. was founded in 2013 by a group of experienced scientists with broad research experience in immunology. We saw a market need to provide a range of antibody related tools and services to support basic and clinical immunological researchers. Our vision and motivation is to become a trusted and leading solution provider to the immunotherapy industry by developing innovative products that provide adequate evaluation tools for the treatment of cancer and autoimmune diseases in academic and clinical studies. Utilizing a state of the art facility located in Norcross, GA, we have successfully established a list of more than 600 products comprising high quality, purified and fluorescent conjugated, monoclonal and secondary antibodies.
The mission of Caprico Biotechnologies is to produce and commercialize monoclonal and polyclonal antibodies with the highest standard of quality to be used in basic and clinical research as well as to assist in the diagnosis and treatment of various types of diseases.